C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle

被引:46
|
作者
Orvieto, R [1 ]
Chen, R
Ashkenazi, J
Ben-Harush, A
Bar, J
Fisch, B
机构
[1] Rabin Med Ctr, Dept Obstet & Gynecol, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
BMI; C-reactive protein; follicular fluid; ovulation induction; sex steroids;
D O I
10.1093/humrep/deh089
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The aim of the present study was to determine serum and follicular fluid C-reactive protein (CRIP) levels in patients undergoing controlled ovarian hyperstimulation (COH) for IVF-embryo transfer cycle, and their possible correlation to COH variables. PATIENTS AND METHODS: The subjects were 16 consecutive patients undergoing our routine IVF long GnRH agonist protocol. Blood was drawn three times during the COH cycle: (i) the day on which adequate suppression was obtained (Day-S); (ii) the day of, or prior to HCG administration (Day-HCG); and (iii) the day of (and before) oocyte pick-up (Day-OPU). Levels of sex steroids and serum and follicular fluid CRP were compared among the three time points. Serum and follicular fluid CRP were measured with a commercial immunoturbidimetric assay. RESULTS: Serum levels of CRP were significantly higher on Day-OPU and Day-HCG than on Day-S, and significantly higher on Day-OPU than on Day-HCG. No difference was observed between follicular and serum CRP levels on Day-OPU. No significant correlations were found between serum and follicular fluid CRP, or between serum CRP-to-BMI ratio and serum sex steroid levels or IVF treatment variables. CONCLUSIONS: The significant increase in serum CRP levels during COH, especially after HCG administration, suggests that COR potentiates a state of systemic inflammation.
引用
收藏
页码:357 / 359
页数:3
相关论文
共 50 条
  • [31] Homocysteine and C-reactive protein levels in haemodialysis patients
    Koulouridis E.
    Tzilianos M.
    Katsarou A.
    Costimba I.
    Klonou E.
    Panagiotaki E.
    Georgalidis C.
    Krokida A.
    Delaportas N.
    Lachanas A.
    Karaliotas G.
    Kaliolia I.
    [J]. International Urology and Nephrology, 2001, 33 (2) : 207 - 215
  • [32] C-reactive protein levels in patients with aggressive periodontitis
    Salzberg, Trang N.
    Overstreet, Benjamin T.
    Rogers, Jeffrey D.
    Califano, Joseph V.
    Best, Al M.
    Schenkein, Harvey A.
    [J]. JOURNAL OF PERIODONTOLOGY, 2006, 77 (06) : 933 - 939
  • [33] C-REACTIVE PROTEIN IN PATIENTS UNDERGOING CARDIAC-SURGERY
    BORALESSA, H
    DEBEER, FC
    MANCHIE, A
    WHITWAM, JG
    PEPYS, MB
    [J]. ANAESTHESIA, 1986, 41 (01) : 11 - 15
  • [34] Preprocedural C-reactive protein levels predict stroke and death in patients undergoing carotid stenting
    Groeschel, K.
    Ernemann, U.
    Larsen, J.
    Knauth, M.
    Schmidt, F.
    Artschwager, J.
    Kastrup, A.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2007, 28 (09) : 1743 - 1746
  • [35] Prognostic role of C-reactive protein levels in patients with hepatocellular carcinoma undergoing sorafenib therapy
    Lee, Jean Kyung
    Harding, James J.
    Chou, Joanne F.
    Capanu, Marinela
    Saltz, Leonard
    Abou-Alfa, Ghassan K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [36] C-reactive Protein Levels Are an Independent Predictor Of Mortality in Patients Undergoing Percutaneous Coronary Intervention
    Bansilal, Sameer
    Aneja, Ashish
    Kini, Annapooma S.
    Muntner, Paul
    Sharma, Samin
    Farkouh, Michael E.
    [J]. CIRCULATION, 2008, 118 (18) : S1104 - S1105
  • [37] The usage of Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, X.
    Fu, Y.
    [J]. HUMAN REPRODUCTION, 2016, 31 : 420 - 421
  • [38] Higher C-reactive protein levels during IVF stimulation are associated with ART failure
    Levin, Ishai
    Gamzu, Ronni
    Mashiach, Roy
    Lessing, Joseph B.
    Amit, Ami
    Almog, Benny
    [J]. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2007, 75 (02) : 141 - 144
  • [39] Serum retinol-binding protein-4 levels in polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in-vitro fertilization cycle
    Orvieto, R.
    Shuhat, V.
    Liberty, G.
    Homburg, R.
    Anteby, E. Y.
    Nahum, R.
    Rabinson, J.
    Meltcer, S.
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2010, 37 (02): : 100 - 104
  • [40] The serum level of C-reactive protein in patients undergoing GnRH agonist protocols for in vitro fertilization cycle
    Liu, B.
    Zhang, L.
    Guo, R. W.
    Wang, W. J.
    Duan, X. Q.
    Liu, Y. W.
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2014, 41 (02): : 190 - 194